Jupiter Neurosciences, Inc.: Jupiter Neurosciences Partners with Zina Biopharmaceuticals to ...
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based ...
Business Insider9 天
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson ...
JOTROL’s innovative micellar formulation overcomes the historical limitations of resveratrol by ... “This partnership with Zina marks a significant milestone for Jupiter as we advance JOTROL into ...
FierceBiotech23 天
Boehringer's phase 3 schizophrenia program misses primary goal
The phase 3 program missed both primary and key secondary endpoints, with no statistically significant effects on relevant measures observed for patients receiving investigational treatment ...
Medical Xpress25 天
Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer
according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. "KATHERINE is a landmark clinical ...